Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

December
18
2019

SRT-100™: Cure Your Patients with This Revolutionary Non-Surgical Squamous Cell Carcinoma Treatment

Each year, there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and colon. Nearly four million people in the United States will be diagnosed with basal…

November
21
2019

Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference

BOCA RATON, Fla., Nov. 21, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced today that Joe Sardano,…

November
06
2019

Sensus Healthcare Reports Third Quarter 2019 Financial Results

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 06, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for…

November
01
2019

Sensus Healthcare to Host Third Quarter 2019 Financial Results and Business Update Conference Call on November 6, 2019

BOCA RATON, Fla., Nov. 01, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry